YEREVAN, January 10. / ARKA /. VivaCell-MTS General Manager Ralph Yirikian, BirthLink NGO Director Kathy Mellor and Dr. Pavel Mazmanyan, the Chief Neonatologist of Armenia, visited neonatal departments in Vedi and Artashat hospitals, Ararat region, which had received equipment for immediate reanimation and warming of sick and small babies, monitoring and management of respiratory difficulties and delivering intravenous fluids.
“In the long-run, the neonatal care project is aimed at the reduction of infant mortality in Armenia. And as an important step in this direction is improved access to medical services in the regions. All hospitals in the regions and capital Yerevan included in the project have been provided with vital equipment and devices. The issue of geographical access persists particularly in the regions, especially those that are socially vulnerable and include the borderland settlements. Too often, taking a newborn to the well-equipped hospital in the capital to provide the necessary care can prove inefficient, because of the loss of time. Project will result in drastic reduction in the rate of transfers to hospitals in Yerevan, which is connected to expenditures. People in the regions should have equal opportunities to receive medical services, especially when it comes to infants,” VivaCell-MTS General Manager Ralph Yirikian commented.
For the sixth year in a row VivaCell-MTS together with BirthLink NGO makes efforts aimed at reducing the level of infant mortality in our country. More than 465 million drams have already been invested by VivaCell-MTS for equipping 34 maternity hospitals throughout Armenia – 12 in Yerevan and 22 in the marzes.
VivaCell-MTS is owned by Russian Mobile Telesystems (80 percent) and Lebanse Fattouch Group (20%). ($1 – 408.09 drams). .-0-